VAL-083 Fails to Outperform SOC in Glioblastoma
VAL-083 did not improve efficacy compared with standard-of-care approaches in patients with glioblastoma.
Roberte Hoffman Meredith Buxton Global Coalition Of Adaptive Research European Association Of Neuro Global Coalition Adaptive Research
Source: onclive.com